Upexi

UPXI · NASDAQ

$0.8805−$0.0295 (−3.24%)TodayMarket closed ·
Prev close $0.91

About UPXI

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space. Its brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX gummies deliver energy without the crash or jitters, offering an alternative to traditional caffeinated beverages. The company is focused on the cryptocurrency industry and the management of cash assets through a cryptocurrency portfolio, primarily focused on Solana tokens and staking of those tokens. The firm utilizes accrual mechanisms in intelligent capital issuance, staking, and discounted locked token purchases.

Employees
59
Headquarters
Tampa, Florida
Listed
Jun 24, 2021
Sector
Consumer Staples
Industry
Personal Care Products

UPXI key statistics

Market cap
77.64M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.13M
Volume
1.57M
Open price
$0.9127
High today
$0.9434
Low today
$0.8711
52 Week high
$5.78
52 Week low
$0.54

Upexi (UPXI) at a glance

As of Oct 20, 2026, Upexi (UPXI) shares are priced at $0.8805, giving the company a market cap of 77.64M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.8711 and $0.9434. The current price is 1.1% above the day's low and 6.7% below its high.

Volume so far is 1.57M shares, below the average of 3.13M shares a day.

Over the past year Upexi has ranged from $0.54 to $5.78, and now sits 6% of the way up that range.

Upexi met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q4 FY26 it reported -$0.21 per share against an estimate of -$0.1224.

The average analyst price target is $5.10, 479.2% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $5.10
Low
$2.02
Now
$0.8805
High
$8.40

UPXI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 23.7% on average.

  1. Q1 FY24: reported -$1.40 per share against an estimate of -$1.84
  2. Q2 FY24: reported -$2.00 per share against an estimate of -$1.02
  3. Q3 FY24: reported -$4.00 per share against an estimate of -$2.04
  4. Q4 FY25: reported -$2.94 per share against an estimate of -$0.051
  5. Q1 FY26: reported -$1.67 per share against an estimate of -$0.204
  6. Q2 FY26: reported -$2.94 per share against an estimate of -$0.051
  7. Q3 FY26: reported -$1.67 per share against an estimate of -$0.204
  8. Q4 FY26: reported -$0.21 per share against an estimate of -$0.1224

UPXI news

  • Press releaseGlobe Newswire

    Upexi to Participate in Upcoming October Investor Conferences

  • Press releaseGlobe Newswire

    Upexi Reports Financial Results for Fiscal Year Ended June 30, 2026

  • Press releaseGlobe Newswire

    Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET

  • Press releaseGlobe Newswire

    Upexi Amends BitGo Credit Facility

  • Press releaseGlobe Newswire

    Upexi Partners with Blueprint to Stake Solana Treasury Assets

  • Press releaseGlobe Newswire

    Upexi Added to the Russell Microcap® Index

  • Press releaseGlobe Newswire

    Upexi Reports Fiscal Third Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19

Similar companies

Companies in the same industry as Upexi

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.